Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Eritoran is a synthetic lipid that inhibits the receptor TLR4. It was developed as a potential treatment for severe sepsis, an excessive inflammatory response to an infection. It failed a five year Phase III clinical trial, the results of which were published in 2013, and as of 2014 was no longer being developed.
The analysis highlights Companies and Overview as prominent areas in the source structure around Eritoran.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Eritoran shows recurring relationship patterns in the source. For example, Eritoran → Interactive image Another extracted example is Eritoran → none. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
tlr4 developed part lipid inhibits sepsis triggering defense binds salt tetrasodium receptor infection sodium pathogens synthetic potential treatment severe excessive
TTTA extracted 16 structured relationships around Eritoran. Examples in this analysis include Eritoran → 3D model (JSmol) → Interactive image and Eritoran → ATC code → none. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Eritoran | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Eritoran | ATC code | none | 1.00 | infobox |
| Eritoran | CAS Number | 185955-34-4 N 185954-98-7 (tetrasodium salt) | 1.00 | infobox |
| Eritoran | ChEMBL | ChEMBL501259 N | 1.00 | infobox |
| Eritoran | ChemSpider | 5288721 N | 1.00 | infobox |
| Eritoran | CompTox Dashboard (EPA) | DTXSID60873217 | 1.00 | infobox |
| Eritoran | DrugBank | DB04933 N | 1.00 | infobox |
| Eritoran | Formula | C66H126N2O19P2 | 1.00 | infobox |
| Eritoran | IUPHAR/BPS | 4919 | 1.00 | infobox |
| Eritoran | KEGG | DG01426 N | 1.00 | infobox |
| Eritoran | Molar mass | 1313.677 g·mol−1 | 1.00 | infobox |
| Eritoran | Other names | E 5564 | 1.00 | infobox |
| Eritoran | PubChem CID | 6912404 | 1.00 | infobox |
| Eritoran | Routes of administration | Intravenous injection | 1.00 | infobox |
| Eritoran | UNII | 551541VI0Y | 1.00 | infobox |
| Eritoran | is a | synthetic lipid that inhibits the receptor TLR4 | 0.90 | text |
The concept neighborhoods around Eritoran bring nearby vocabulary together. In this analysis, examples include Tlr4, Binds and Lipid. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the Eritoran map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Eritoran to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Companies & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Eritoran · EN edition · Analysis: TopicsToTalkAbout